Apple, IBD Stock Of The Day, Set To Enter New Market
Apple, IBD Stock Of The Day, Set To Enter New Market Investor's Business Daily
Covered in this story
Analyst targets on Apple Inc.
- Morgan Stanley: $330 → $355 by Oct 2027 · Overweight via Investing.com
- Jefferies: $308 → $264 by Aug 2027 · Underperform via Seeking Alpha
- Wedbush: $313 → $400 by Aug 2027 · Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $AAPL yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Apple Inc. →Dalsna Finance is currently tracking 54 stories mentioning Apple Inc., the earliest published 14 Aug 2026.
Summary aggregated from Investor's Business Daily's public RSS feed. The full reporting belongs to Investor's Business Daily — please read it on their site.